India’s current production capacity of HCQ is 35-40 cr tablets a month: IDMA
Senior vice president of Indian Drug Manufacturers’ Association (IDMA), Viranchi Shah said that India’s current production capacity of Hydroxychloroquine is 35-40 crore tablets a month. While speaking to ANI, he said, “India holds almost 70% global capacity of manufacturing Hydroxychloroquine (HCQ). Our current production capacity of Hydroxychloroquine is 35-40 crore tablets a month. This is 10 times more than our requirement. There is no shortage of HCQ in India and we have sufficient amount of it to supply outside.”
Apr 24, 2020, 12:54 PM IST
IDMA seeks exemptions for R&D, samples
Indian Drug Manufacturers' Association (IDMA) Wednesday asked the government that 'control samples' and samples given to physicians be exempted from duties and taxes in the Budget.
Jun 25, 2014, 20:49 PM IST
